These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 22349986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
    Brændengen M, Tveit KM, Bruheim K, Cvancarova M, Berglund Å, Glimelius B.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1017-24. PubMed ID: 20932687
    [Abstract] [Full Text] [Related]

  • 3. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment?
    Lombardi R, Cuicchi D, Pinto C, Di Fabio F, Iacopino B, Neri S, Tardio ML, Ceccarelli C, Lecce F, Ugolini G, Pini S, Di Tullio P, Taffurelli M, Minni F, Martoni A, Cola B.
    Ann Surg Oncol; 2010 Mar 15; 17(3):838-45. PubMed ID: 20012700
    [Abstract] [Full Text] [Related]

  • 4. Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial.
    Sclafani F, Peckitt C, Cunningham D, Tait D, Giralt J, Glimelius B, Keränen SR, Bateman A, Hickish T, Tabernero J, Thomas J, Brown G, Oates J, Chau I.
    Int J Radiat Oncol Biol Phys; 2015 Oct 01; 93(2):303-12. PubMed ID: 26031368
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term quality-of-life after neoadjuvant short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer.
    Guckenberger M, Saur G, Wehner D, Thalheimer A, Kim M, Germer CT, Flentje M.
    Radiother Oncol; 2013 Aug 01; 108(2):326-30. PubMed ID: 24021342
    [Abstract] [Full Text] [Related]

  • 7. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 8. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer.
    Urso E, Serpentini S, Pucciarelli S, De Salvo GL, Friso ML, Fabris G, Lonardi S, Ferraro B, Bruttocao A, Aschele C, Nitti D.
    Eur J Surg Oncol; 2006 Dec 01; 32(10):1201-8. PubMed ID: 16872799
    [Abstract] [Full Text] [Related]

  • 9. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
    Lim SB, Choi HS, Jeong SY, Kim DY, Jung KH, Hong YS, Chang HJ, Park JG.
    Ann Surg; 2008 Aug 01; 248(2):243-51. PubMed ID: 18650634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH, Lee KC, Choi JH, Oh JH, Baek JH, Park SH, Shin DB.
    Jpn J Clin Oncol; 2008 Feb 01; 38(2):112-21. PubMed ID: 18263881
    [Abstract] [Full Text] [Related]

  • 12. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
    An X, Lin X, Wang FH, Goodman K, Cai PQ, Kong LH, Fang YJ, Gao YH, Lin JZ, Wan DS, Pan ZZ, Ding PR.
    Eur J Cancer; 2013 Mar 01; 49(4):843-51. PubMed ID: 23063351
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
    Bonnetain F, Bosset JF, Gerard JP, Calais G, Conroy T, Mineur L, Bouché O, Maingon P, Chapet O, Radosevic-Jelic L, Methy N, Collette L.
    Eur J Cancer; 2012 Aug 01; 48(12):1781-90. PubMed ID: 22507892
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    Cancer and Leukemia Group B 89901Massachusetts General Hospital Cancer Center, Boston MA 02114, USA. dpryan@partners.org, Ryan DP, Niedzwiecki D, Hollis D, Mediema BE, Wadler S, Tepper JE, Goldberg RM, Mayer RJ.
    J Clin Oncol; 2006 Jun 01; 24(16):2557-62. PubMed ID: 16636336
    [Abstract] [Full Text] [Related]

  • 19. [Rectal cancer: current status of multimodal therapy--when and how?].
    Gaedcke J, Liersch T, Hess C, Becker H, Rödel C, Ghadimi BM.
    Zentralbl Chir; 2011 Aug 01; 136(4):334-42. PubMed ID: 21863511
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.